
ABOUT CATALENT
Catalyst + Talent. Our name combines these ideas. As the world’s #1 drug development, delivery and supply partner with over 80 years of experience, we are the catalyst for your success. We have helped thousands of innovators by optimizing and manufacturing thousands of pharmaceutical, biologic, consumer health and beauty products utilizing our superior and innovative drug delivery technologies to improve their value to patients and consumers.
Catalent is a vibrant growing community of 8,500 global employees with the passion to unlock the potential of your product. Founded in 2007 as Catalent, our legacy of drug development goes much deeper, incorporating the inventions and innovations which have transformed the pharmaceutical industry. On July 30, 2014 Catalent announced its initial public offering and became a publicly traded on the New York Stock Exchange under the ticker symbol CTLT.
From early development to clinical supply and commercial manufacturing, our 30+ global site teams support you through all phases of development, delivery, and supply, accelerating your product’s path to market in segments such as pharmaceuticals, biologics, consumer health and beauty, and animal health utilizing our superior drug delivery technologies to improve therapeutic and product value to patients and consumers.
Whether you seek a single tailored solution or partnership through your product’s entire life cycle, we put our experience, expertise, and passion to work for you in unlocking the potential of your product.
CONTACT INFORMATION
Catalent
14 Schoolhouse Road
Somerset, NJ 08873
UNITED STATES
Phone: 877-587-1835
FEATURED ARTICLES
- Keys To A Successful Rapid Commercial Launch
- NMR And Mass Spectrometry In Pharmaceutical Development
- Analyzing Product Formulation Using Raman Spectroscopy
- Principles Of Raman Spectroscopy And Application To Pharmaceutical Development
- How Protocol Design Drives Comparator Sourcing Cost, Timelines, Complexity, And Risk
- Data, Relationships, And Experience In Comparator Sourcing Success
- Accelerating Timelines By Planning For Clinical Supplies In Advance
- APAC Region Distribution Considerations For Clinical Trial Supplies
- Expanded Access And Commercial Packaging Strategies For Orphan, Niche, And Low-Volume Drugs
- Minimizing Bias When Blinding And Masking Drug Products
- Establishing Parameters For Success
- Innovative Strategies To Maintain Product Integrity In Biologic & Biosimilar Clinical Studies
- Expediting Path To Clinic With OptiForm® Total Supply
- Strategies For Flexible Manufacturing
- Quality By Design Approach To Analytical Method Optimization
- Zydis® Bio Technology, Grazax® & Grastek®: Revolutionizing Allergy Therapy
- Zydis® ODT Provides Better Treatments
- Rapid Global Characterization Of Immunoglobulin G1 Following Oxidative Stress
- High-Throughput Preformulation Development Platform For Biologics
- Analytical Quality By Design Using Design Of Experiments
WEBINARS & VIDEOS
- Biologics Drug Product: Formulation, Tech Transfer, Delivery Strategies
- The Product Development Superhighway: Leveraging End-to-End Solutions For Market Success
- Supply Chain Models For Global Trials: Singapore As The APAC Gateway To The World
- Perceptions, Myths And New Thinking On Direct-To-Patient Clinical Supply
- Innovative & Flexible Solutions For An E2E Patient Centric, Lean Clinical Supply Chain
- Beyond Brexit: What Now For Clinical Supply Across Europe?
- The Art Of Recognizing Clinical Supply Risk Factors
- Accelerating Clinical Supply In China and Beyond
- Rapid Developability Assessment Of Early Phase Molecules
- Elemental Impurities Risk Assessment For Finished Drug Products
- Advanced Analytical Tools For Drug Product Development
- A Roadmap For Early Development To Commercial Manufacturing
- Strategies To Develop Lipid-Based Drug Delivery Systems And Oral Dosage Forms
- The Next Generation ODT
- Venerated And Vital: Using Lipid Based Delivery For Fast And Efficient Early Phase Development
- Real World Dosing Solutions For Patients
- Demand Led Services and Clinical Supply Efficiency
- Fast Track To Early Development From Candidate Selection To Phase 1
- Bioavailability Enhancement Through Spray-Dried Dispersions